Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 9;9(12):1934.
doi: 10.3390/children9121934.

Systemic Lidocaine Infusions for Pediatric Patients with Cancer-Related Pain

Emily Rav  1 , Rachna Sheth  2 , Ali H Ahmad  3
Affiliations
Review

Systemic Lidocaine Infusions for Pediatric Patients with Cancer-Related Pain

Emily Rav et al. Children (Basel). .

Abstract

Pediatric patients with cancer experience significant distress from both treatment and cancer-related pain. Careful selection of an analgesic regimen should be based upon individual patient factors, including the level of pain, response to therapy, and physiologic profile. Refractory pain is a therapeutic dilemma frequently encountered in the pediatric cancer setting. Systemic lidocaine infusions have been described as both safe and efficacious, as prior studies show patients reporting decreased pain scores and improved quality of life after lidocaine treatment. Given the favorable side effect profile of lidocaine, it has the potential to be considered for analgesia in the setting of refractory pain. This review discusses the use of systemic lidocaine infusions for analgesia in pediatric oncology patients with cancer-related pain.

Keywords: analgesia; cancer; children; lidocaine; oncology; pain; pediatrics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Tutelman P.R., Chambers C.T., Stinson J.N., Parker J.A., Fernandez C.V., Witteman H.O., Nathan P.C., Barwick M., Campbell F., Jibb L.A., et al. Pain in Children With Cancer: Prevalence, Characteristics, and Parent Management. Clin. J. Pain. 2018;34:198–206. doi: 10.1097/AJP.0000000000000531. - DOI - PubMed
    1. Wiffen P.J., Cooper T.E., Anderson A.K., Gray A.L., Grégoire M.C., Ljungman G., Zernikow B. Opioids for cancer-related pain in children and adolescents. Cochrane Database Syst. Rev. 2017;7:Cd012564. doi: 10.1002/14651858.CD012564.pub2. - DOI - PMC - PubMed
    1. Murnion B.P. Neuropathic pain: Current definition and review of drug treatment. Aust. Prescr. 2018;41:60–63. doi: 10.18773/austprescr.2018.022. - DOI - PMC - PubMed
    1. Mishra S., Bhatnagar S., Singh M., Gupta D., Jain R., Chauhan H., Goyal G.N. Pediatric cancer pain management at a regional cancer center: Implementation of WHO Analgesic Ladder. Middle East J. Anaesthesiol. 2009;20:239–244. - PubMed
    1. Moody K., Baig M., Carullo V. Alleviating Terminal Pediatric Cancer Pain. Children. 2021;8:239. doi: 10.3390/children8030239. - DOI - PMC - PubMed

LinkOut - more resources